Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of Toronto

$321,300.00

Cell-based senotherapy through synthetic biology

FY 2017-18

Summary
Studies into the removal of 'old' cells in mice have shown that this results in a stunning reversal of aging where the mice lived longer and healthier. These mice however were genetically engineered such that their 'old' cells can be triggered to die by ingesting an antibiotic drug. How can we find these 'old' cells in a normal mouse and ultimately human without the aid of such genetic manipulations? As it turns out, 'old' cells produce signals that can be tracked like the ringing signal of your cell phone in a dark room. This proposal is about engineering a cell to follow these signals to the 'old' cells. Once at the site, the engineered cell will release a biological chemical that kills the 'old' cells. The engineered cell has a suicide gene that converts a particular antiviral drug that is normally not toxic to a form that is very toxic. Hence, after ingesting the antiviral drug, the engineered cell will die. This type of therapeutic intervention is similar to what happens when the cells of our immune system are functioning at their best. Immune cells adeptly detect disease conditions and then respond specifically and locally to minimize side-effects.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
368739
Name
Truong Kien K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Biological and Clinical Aspects of Aging
Projecttitle
Cell-based senotherapy through synthetic biology
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$321,300
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Calcium Signaling; Cell Fusion; Cell Migration; Cell-Based Therapy; Protein Engineering; Senescence; Synthetic Biology
Abstract
Studies into the removal of 'old' cells in mice have shown that this results in a stunning reversal of aging where the mice lived longer and healthier. These mice however were genetically engineered such that their 'old' cells can be triggered to die by ingesting an antibiotic drug. How can we find these 'old' cells in a normal mouse and ultimately human without the aid of such genetic manipulations? As it turns out, 'old' cells produce signals that can be tracked like the ringing signal of your cell phone in a dark room. This proposal is about engineering a cell to follow these signals to the 'old' cells. Once at the site, the engineered cell will release a biological chemical that kills the 'old' cells. The engineered cell has a suicide gene that converts a particular antiviral drug that is normally not toxic to a form that is very toxic. Hence, after ingesting the antiviral drug, the engineered cell will die. This type of therapeutic intervention is similar to what happens when the cells of our immune system are functioning at their best. Immune cells adeptly detect disease conditions and then respond specifically and locally to minimize side-effects.
Competitiondate
201709
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Truong, Kien K
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $321,300~ $0~
University of Toronto - $321,300 Grant (2017-18) | Canada Spends